Avantor, Inc. (AVTR)
15.14
-0.51
(-3.26%)
USD |
NYSE |
Nov 05, 16:00
15.14
0.00 (0.00%)
Pre-Market: 20:00
Avantor SG&A Expense (TTM) : 1.604B for Sept. 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.604B |
| June 30, 2026 | 1.599B |
| March 31, 2026 | 1.609B |
| December 31, 2025 | 1.596B |
| September 30, 2025 | 1.574B |
| June 30, 2025 | 1.624B |
| March 31, 2025 | 1.604B |
| December 31, 2024 | 1.641B |
| September 30, 2024 | 1.657B |
| June 30, 2024 | 1.585B |
| March 31, 2024 | 1.537B |
| December 31, 2023 | 1.507B |
| September 30, 2023 | 1.482B |
| June 30, 2023 | 1.489B |
| March 31, 2023 | 1.483B |
| December 31, 2022 | 1.473B |
| September 30, 2022 | 1.543B |
| June 30, 2022 | 1.547B |
| Date | Value |
|---|---|
| March 31, 2022 | 1.567B |
| December 31, 2021 | 1.530B |
| September 30, 2021 | 1.474B |
| June 30, 2021 | 1.424B |
| March 31, 2021 | 1.377B |
| December 31, 2020 | 1.374B |
| September 30, 2020 | 1.325B |
| June 30, 2020 | 1.327B |
| March 31, 2020 | 1.375B |
| December 31, 2019 | 1.369B |
| September 30, 2019 | 1.374B |
| June 30, 2019 | 1.390B |
| March 31, 2019 | 1.391B |
| December 31, 2018 | 1.406B |
| September 30, 2018 | 1.53B |
| June 30, 2018 | 1.184B |
| March 31, 2018 | 809.90M |
| December 31, 2017 | 457.20M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Champions Oncology, Inc. | 21.81M |
| Medpace Holdings, Inc. | 192.70M |
| Personalis, Inc. | 54.00M |
| Adaptive Biotechnologies Corp. | 138.95M |
| 10X Genomics, Inc. | 297.01M |